Old Web
English
Sign In
Acemap
>
authorDetail
>
Luca Mancinelli
Luca Mancinelli
University of Bologna
Medicine
Multiple sclerosis
Teriflunomide
Pharmacology
Discontinuation
4
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Teeth loss after teriflunomide treatment: Casual or causal? A short case series
2018
Multiple sclerosis and related disorders
Veria Vacchiano
Nicola Frattaruolo
Luca Mancinelli
Matteo Foschi
Antonio Carotenuto
Cinzia Scandellari
Maurizio Piattelli
Vincenzo Morra
Alessandra Lugaresi
Show All
Source
Cite
Save
Citations (2)
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients with Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship
2018
Clinical Neuropharmacology
Manuela Contin
Luca Mancinelli
Alessandro Perrone
Loredana Sabattini
Susan Mohamed
Cinzia Scandellari
Matteo Foschi
Veria Vacchiano
Alessandra Lugaresi
Roberto Riva
Show All
Source
Cite
Save
Citations (2)
“Nail loss after teriflunomide treatment: A new potential adverse event”
2017
Multiple sclerosis and related disorders
Luca Mancinelli
P. Amerio
M. Di Ioia
V. Di Tommaso
G. De Luca
Marco Onofrj
Alessandra Lugaresi
Show All
Source
Cite
Save
Citations (3)
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience.
2014
Neurological Sciences
Luca Mancinelli
V. Di Tommaso
D. Farina
Daniela Travaglini
M. Di Ioia
Erika Pietrolongo
G. De Luca
Marco Onofrj
Alessandra Lugaresi
Show All
Source
Cite
Save
Citations (0)
1